Zobrazeno 1 - 10
of 30
pro vyhledávání: '"K. Demesmay"'
Publikováno v:
Le Pharmacien Clinicien. 57:e84
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Revue du Rhumatisme. 88:A64-A65
Autor:
L. Widawski, Christelle Sordet, Laurent Messer, K. Demesmay, S. Geneton, J. Walther, M. Ardizzone
Publikováno v:
Revue du Rhumatisme. 88:A64
Introduction Mise en place d’un dispositif d’accompagnement de reprise d’activite physique « RAP » pour les patients ayant un rhumatisme inflammatoire chronique (RIC) au sein des hopitaux de Colmar, Mulhouse, Strasbourg depuis octobre 2020. I
Autor:
Jean-Louis Lorenzini, Marie Anne Bertrand, Marie-Christine Woronoff-Lemsi, Patricia Pouzol, E. Tissot, Virginie Nerich, K. Demesmay, M. E. Briquel, Albert Faradji
Publikováno v:
Pharmacy World & Science. 30:287-292
Objective The aim of this study was to assess the consumption of anti-haemophilic drugs by adults and children with severe haemophilia A or B (residual activity of FVIII or FIX ≤2%) and to quantify the average direct medical costs. Method A retrosp
Autor:
Marie-Christine Woronoff-Lemsi, M. Jacquet, J.-P Drouhin, K. Demesmay, E. Tissot, Samuel Limat
Publikováno v:
Pharmacy World and Science. 23:102-106
Objective: A major objective of centralized preparation is to improve the quality of the final product, and thus their safety for the patient. Few data are available concerning errors occurring during preparation and the risk factors associated with
Autor:
Jean-Yves Cahn, K. Demesmay, Evelyne Racadot, Marie-Anne Bertrand, Claude-Eric Bulabois, Marie-Christine Woronoff-Lemsi, E. Tissot, Eric Deconinck
Publikováno v:
Transplantation. 74:1190-1192
Background. Hemorrhagic cystitis (HC) is an important cause of morbidity in patients undergoing allogeneic stem-cell transplantation (SCT). Various causes have been identified, such as the use of high-dose cyclophosphamide or busulfan and the occurre
Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's Lymphoma
Autor:
Laurent Voillat, Patrick Arveux, Marie-Christine Woronoff-Lemsi, Jean-Yves Cahn, Eric Deconinck, K. Demesmay, Yvette Bernard, Annie Brion, Samuel Limat, Philippe Fagnoni
Publikováno v:
Clinical drug investigation. 25(11)
Objective: The cardiotoxicity of anthracyclines remains a key problem in patients with aggressive non-Hodgkin’s lymphoma (NHL). With regard to the actual long-term prognosis of aggressive NHL, the development of cardioprotective strategies is manda
Publikováno v:
Soins; la revue de reference infirmiere. (661)
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 49:236